Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotection in Glaucoma: Animal Models and Clinical Trials
Mohammadali Almasieh, Leonard A. Levin
Annual Review of Vision Science (2017) Vol. 3, Iss. 1, pp. 91-120
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Reprogramming to recover youthful epigenetic information and restore vision
Yuancheng Ryan Lu, Benedikt Brommer, Xiao Tian, et al.
Nature (2020) Vol. 588, Iss. 7836, pp. 124-129
Open Access | Times Cited: 625
Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
Kevin A. Guttenplan, Benjamin K. Stafford, Rana N. El‐Danaf, et al.
Cell Reports (2020) Vol. 31, Iss. 12, pp. 107776-107776
Open Access | Times Cited: 187
Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Xinzheng V. Guo, Jing Zhou, Christopher R. Starr, et al.
Cell (2021) Vol. 184, Iss. 16, pp. 4299-4314.e12
Open Access | Times Cited: 130
Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells
Feng Tian, Yuyan Cheng, Songlin Zhou, et al.
Neuron (2022) Vol. 110, Iss. 16, pp. 2607-2624.e8
Open Access | Times Cited: 91
Oxidative stress in the eye and its role in the pathophysiology of ocular diseases
Elsa Wilma Böhm, Francesco Buonfiglio, Anna Maria Voigt, et al.
Redox Biology (2023) Vol. 68, pp. 102967-102967
Open Access | Times Cited: 87
Prevalence of Primary Angle Closure Glaucoma in the Last 20 Years: A Meta-Analysis and Systematic Review
Nan Zhang, Jiaxing Wang, Biyue Chen, et al.
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 101
Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma
Uday B. Kompella, Rachel R. Hartman, Madhoosudan A. Patil
Progress in Retinal and Eye Research (2020) Vol. 82, pp. 100901-100901
Open Access | Times Cited: 84
Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma
Milica A. Margeta, Zhuoran Yin, Charlotte Madore, et al.
Immunity (2022) Vol. 55, Iss. 9, pp. 1627-1644.e7
Open Access | Times Cited: 70
Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update
Ru Hui Sim, Srinivasa Rao Sirasanagandla, Srijit Das, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 534-534
Open Access | Times Cited: 46
Protective effect of the natural flavonoid naringenin in mouse models of retinal injury
Ling Zeng, Ying Qian, Hongdou Lou, et al.
European Journal of Pharmacology (2023) Vol. 962, pp. 176231-176231
Closed Access | Times Cited: 28
Oxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases?
Francesco Buonfiglio, Elsa Wilma Böhm, Norbert Pfeiffer, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1465-1465
Open Access | Times Cited: 27
Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress
Yuening Shen, Jianguo Sun, Xinghuai Sun
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments
Ghazi O. Bou Ghanem, Lauren K. Wareham, David J. Calkins
Progress in Retinal and Eye Research (2024) Vol. 100, pp. 101261-101261
Open Access | Times Cited: 16
Circular RNA-based therapy provides sustained and robust neuroprotection for retinal ganglion cells
Wenbing Jiang, Dongchang Xiao, Cheng Wu, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102258-102258
Open Access | Times Cited: 9
Apelin-13 attenuates optic nerve damage in glaucomatous mice by regulating glucose metabolism
Ya Zhang, Jiajun Zhao, Jian Zhou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies
Sidra Zafar, Mira M. Sachdeva, Benjamin J. Frankfort, et al.
Current Diabetes Reports (2019) Vol. 19, Iss. 4
Open Access | Times Cited: 56
Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies
Najam A. Sharif
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50
Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art
Lidawani Lambuk, Mohd Aizuddin Mohd Lazaldin, Suhana Ahmad, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Microglial cGAS–STING signaling underlies glaucoma pathogenesis
Yutong Liu, Ailian Wang, Chen Chen, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 36
Closed Access | Times Cited: 8
Experimental Models of Glaucoma: A Powerful Translational Tool for the Future Development of New Therapies for Glaucoma in Humans—A Review of the Literature
Karine Evangelho, Claudio A. Mastronardi, Alejandra de‐la‐Torre
Medicina (2019) Vol. 55, Iss. 6, pp. 280-280
Open Access | Times Cited: 49
Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
Mihir Shah, Sara Cabrera-Ghayouri, Lori‐Ann Christie, et al.
Pharmaceutical Research (2019) Vol. 36, Iss. 4
Open Access | Times Cited: 46
A Dietary Combination of Forskolin with Homotaurine, Spearmint and B Vitamins Protects Injured Retinal Ganglion Cells in a Rodent Model of Hypertensive Glaucoma
Maurizio Cammalleri, Massimo Dal Monte, Rosario Amato, et al.
Nutrients (2020) Vol. 12, Iss. 4, pp. 1189-1189
Open Access | Times Cited: 44
Can Treatment With Citicoline Eyedrops Reduce Progression in Glaucoma? The Results of a Randomized Placebo-controlled Clinical Trial
Luca Rossetti, Michele Iester, Laura Tranchina, et al.
Journal of Glaucoma (2020) Vol. 29, Iss. 7, pp. 513-520
Open Access | Times Cited: 41
Neuroprotective effect of mesenchymal stem cell-derived extracellular vesicles on optic nerve injury in chronic ocular hypertension
Fei Yu, Yao Wang, Changquan Huang, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 10, pp. 2301-2301
Open Access | Times Cited: 15
Signalling pathways and cell death mechanisms in glaucoma: Insights into the molecular pathophysiology
Devaraj Basavarajappa, Caridad Galindo‐Romero, Vivek Gupta, et al.
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101216-101216
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top